Washington, DC 20006-5349
HELPLINE
This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 26th in Philadelphia, Pennsylvania. This panel is moderated by patient Jessica Blackford-Cleeton and includes mesothelioma patients who have been on or are currently on clinical trials.This panel discussion features mesothelioma patients who are currently participating in,…
This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 26th in Philadelphia, Pennsylvania. Yeong Bae, MSW, LSW, presents on Maintaining Emotional Balance.This presentation focuses on maintaining emotional balance and the vital role of mental health for mesothelioma patients, their caregivers, and family members through the…
This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 26th in Philadelphia, Pennsylvania. This panel includes Jason Foster, MD, from the University of Nebraska, Hedy Kindler, MD, from the University of Chicago, Michael Offin, MD, from Memorial Sloan Kettering Cancer Center, and Georgios Karagkounis, MD,…
Our Patient Services Director, Julie White, RN, BSN, OCN, sits down with Aaron Mansfield, MD. Dr. Mansfield is a medical oncologist and researcher at the Mayo Clinic in Rochester, Minnesota. He discusses multimodality clinical trials with Julie. Our SponsorsMesoTV is a program by the Mesothelioma Applied Research Foundation. This program is…
This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 26th in Philadelphia, Pennsylvania. Kevin Blyth, MD, from University of Glasgow presents on Imaging in the Future with AI. This presentation explores how artificial intelligence (AI) is transforming medical imaging for mesothelioma diagnosis, treatment planning, and…
This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 25th in Philadelphia, Pennsylvania. This panel includes Melina Marmarelis, MD from University of Pennsylvania, Mehmet Altan, MD, from MD Anderson Cancer Center, Adam Bograd, MD, from Swedish Health, and Michael Offin, MD, from Memorial Sloan Kettering…
This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 25th in Philadelphia, Pennsylvania. Carly Roop, RD, CSO, MA, LDN, from University of Pennsylvania presents on Nutrition and Cancer.This presentation focuses on the vital role of nutrition in supporting mesothelioma patients and their families during treatment…
This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 25th in Philadelphia, Pennsylvania. Santhosshi Narayanan, MD, FACP from MD Anderson Cancer Center, presents on Integrative Medicine.This presentation explores the role of integrative medicine in supporting mesothelioma patients and their families throughout diagnosis, treatment, and recovery.…
Vivace Therapeutics, a company that develops cancer treatments, announced on July 30, 2025, that the U.S. Food and Drug Administration (FDA) has granted its experimental drug, VT3989, an “Orphan Drug Designation” (ODD) to treat mesothelioma, a rare and aggressive form of cancer.VT3989 is a TEAD inhibitor. It works by blocking…
Our Patient Services Director, Julie White, RN, BSN, OCN, sits down with Michael Offin, MD to discuss a clinical trial . Dr. Offin is a Thoracic Medical Oncologist at Memorial Sloan Kettering Cancer Center. They discuss a current clinical trial for mesothelioma. Our Sponsors MesoTV is a program by the Mesothelioma…
